No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Sandoz/Samsung Bioepis’ Ustekinumab Biosimilar Launched in EU
On 25 July 2024, Sandoz announced the European launch of Pyzchiva®, biosimilar to Janssen’s Stelara® (ustekinumab) for treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and paediatric plaque psoriasis. Although Pyzchiva® is not the first approved...